Debra Zack - 01 Mar 2022 Form 4 Insider Report for EXAGEN INC. (XGN)

Role
Chief Medical Officer
Signature
/s/ Kamal Adawi, as attorney-in-fact
Issuer symbol
XGN
Transactions as of
01 Mar 2022
Net transactions value
-$23,076
Form type
4
Filing time
02 Mar 2022, 15:41:04 UTC
Previous filing
08 Feb 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction XGN Common Stock Tax liability $23,076 -3,241 -3.7% $7.12 84,259 01 Mar 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares were withheld from the Reporting Person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted on February 23, 2021.